🐢
|
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
26 auth.
C. Teunissen,
A. Petzold,
J. Bennett,
F. Berven,
L. Brundin,
M. Comabella,
D. Franciotta,
J. Frederiksen,
J. Fleming,
R. Furlan,
R. Hintzen,
Steve G. Hughes,
M. Johnson,
E. Krasulová,
J. Kuhle,
...
M. Magnone,
C. Rajda,
K. Rejdak,
H. K. Schmidt,
V. Pesch,
E. Waubant,
C. Wolf,
G. Giovannoni,
B. Hemmer,
H. Tumani,
F. Deisenhammer
|
9 |
2009 |
9 🐢
|
🐜
|
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
9 auth.
T. Berger,
P. Rubner,
F. Schautzer,
R. Egg,
H. Ulmer,
I. Mayringer,
...
E. Dilitz,
F. Deisenhammer,
M. Reindl
|
9 |
2003 |
9 🐜
|
🐜
|
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
12 auth.
M. Freedman,
E. Thompson,
F. Deisenhammer,
G. Giovannoni,
G. Grimsley,
G. Keir,
...
S. Ohman,
M. Racke,
M. Sharief,
C. Sindic,
F. Sellebjerg,
W. Tourtellotte
|
9 |
2005 |
9 🐜
|
🐜
|
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
20 auth.
S. Mader,
Viktoria Gredler,
Kathrin Schanda,
K. Rostásy,
I. Dujmovic,
K. Pfaller,
A. Lutterotti,
S. Jarius,
Franziska Di Pauli,
Bettina Kuenz,
...
R. Ehling,
H. Hegen,
F. Deisenhammer,
F. Aboul‐Enein,
M. Storch,
P. Koson,
J. Drulovic,
W. Kristoferitsch,
T. Berger,
M. Reindl
|
8 |
2011 |
8 🐜
|
🐜
|
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
8 auth.
M. Reindl,
C. Linington,
U. Brehm,
R. Egg,
E. Dilitz,
F. Deisenhammer,
...
W. Poewe,
T. Berger
|
8 |
1999 |
8 🐜
|
🐬
|
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
F. Fazekas,
F. Deisenhammer,
S. Strasser‐Fuchs,
G. Nahler,
B. Mamoli
|
8 |
1997 |
8 🐬
|
🦁
|
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force
7 auth.
F. Deisenhammer,
A. Bartoš,
R. Egg,
N. Gilhus,
G. Giovannoni,
S. Rauer,
...
F. Sellebjerg
|
8 |
2006 |
8 🦁
|
🐜
|
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
99 auth.
J. Kuhle,
G. Disanto,
R. Dobson,
R. Adiutori,
L. Bianchi,
J. Topping,
J. Bestwick,
U. Meier,
M. Marta,
G. Costa,
T. Runia,
E. Evdoshenko,
N. Lazareva,
E. Thouvenot,
P. Iaffaldano,
...
V. Direnzo,
M. Khademi,
F. Piehl,
M. Comabella,
M. Sombekke,
J. Killestein,
H. Hegen,
S. Rauch,
S. D'alfonso,
J. Álvarez-cermeño,
P. Kleinova,
D. Horáková,
Romy Roesler,
F. Lauda,
S. Llufriu,
Timuçin Avşar,
U. Uygunoğlu,
A. Altıntaş,
S. Saip,
T. Menge,
C. Rajda,
R. Bergamaschi,
N. Moll,
M. Khalil,
R. Marignier,
I. Dujmovic,
Henrik Larsson,
C. Malmeström,
E. Scarpini,
C. Fenoglio,
S. Wergeland,
A. Laroni,
Viviana Annibali,
S. Romano,
A. Martínez,
A. Carrá,
M. Salvetti,
A. Uccelli,
Ø. Torkildsen,
K. Myhr,
D. Galimberti,
K. Rejdak,
J. Lycke,
J. Frederiksen,
J. Drulovic,
C. Confavreux,
D. Brassat,
C. Enzinger,
S. Fuchs,
I. Boscá,
J. Pelletier,
C. Picard,
E. Colombo,
D. Franciotta,
T. Derfuss,
R. Lindberg,
Ö. Yaldizli,
L. Vécsei,
B. Kieseier,
H. Hartung,
P. Villoslada,
A. Siva,
A. Saiz,
H. Tumani,
E. Havrdová,
L. Villar,
M. Leone,
N. Barizzone,
F. Deisenhammer,
C. Teunissen,
X. Montalban,
M. Tintoré,
T. Olsson,
M. Trojano,
S. Lehmann,
G. Castelnovo,
Lapin Sv,
R. Hintzen,
L. Kappos,
R. Furlan,
V. Martinelli,
G. Comi,
S. Ramagopalan,
G. Giovannoni
|
8 |
2015 |
8 🐜
|
🦁
|
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial
F. Deisenhammer,
H. Hegen
|
8 |
2012 |
8 🦁
|
🐜
|
Guidelines on use of anti‐IFN‐β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN‐β antibodies in multiple sclerosis
9 auth.
P. S. Sørensen,
F. Deisenhammer,
P. Duda,
R. Hohlfeld,
K. Myhr,
Jacqueline A Palace,
...
C. Polman,
C. Pozzilli,
C. Ross
|
7 |
2005 |
7 🐜
|
🐜
|
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
15 auth.
C. Polman,
A. Bertolotto,
F. Deisenhammer,
G. Giovannoni,
H. Hartung,
B. Hemmer,
J. Killestein,
H. McFarland,
J. Oger,
A. Pachner,
...
J. Petkau,
A. Reder,
S. Reingold,
H. Schellekens,
P. Sørensen
|
7 |
2010 |
7 🐜
|
🦁
|
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies
F. Deisenhammer,
M. Reindl,
J. Harvey,
T. Gasse,
E. Dilitz,
T. Berger
|
7 |
1999 |
7 🦁
|